As of 2025-07-03, the EV/EBITDA ratio of Pulmonx Corp (LUNG) is -1.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LUNG's latest enterprise value is 78.13 mil USD. LUNG's TTM EBITDA according to its financial statements is -54.28 mil USD. Dividing these 2 quantities gives us the above LUNG EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 13.7x | 13.3x |
| Forward P/E multiples | 10.3x - 10.3x | 10.3x |
| Fair Price | (16.61) - (13.11) | (15.13) |
| Upside | -710.7% - -581.8% | -656.2% |
| Date | EV/EBITDA |
| 2025-06-26 | -1.34 |
| 2025-06-25 | -1.37 |
| 2025-06-24 | -1.42 |
| 2025-06-23 | -1.33 |
| 2025-06-20 | -1.37 |
| 2025-06-18 | -1.46 |
| 2025-06-17 | -1.43 |
| 2025-06-16 | -1.63 |
| 2025-06-13 | -1.67 |
| 2025-06-12 | -1.75 |
| 2025-06-11 | -1.84 |
| 2025-06-10 | -1.94 |
| 2025-06-09 | -1.94 |
| 2025-06-06 | -1.77 |
| 2025-06-05 | -1.62 |
| 2025-06-04 | -1.71 |
| 2025-06-03 | -1.78 |
| 2025-06-02 | -1.74 |
| 2025-05-30 | -1.94 |
| 2025-05-29 | -1.80 |
| 2025-05-28 | -1.62 |
| 2025-05-27 | -1.71 |
| 2025-05-23 | -1.73 |
| 2025-05-22 | -1.74 |
| 2025-05-21 | -1.75 |
| 2025-05-20 | -1.91 |
| 2025-05-19 | -1.90 |
| 2025-05-16 | -1.97 |
| 2025-05-15 | -1.96 |
| 2025-05-14 | -1.84 |
| 2025-05-13 | -1.88 |
| 2025-05-12 | -2.15 |
| 2025-05-09 | -1.92 |
| 2025-05-08 | -2.12 |
| 2025-05-07 | -2.15 |
| 2025-05-06 | -1.97 |
| 2025-05-05 | -2.08 |
| 2025-05-02 | -2.22 |
| 2025-05-01 | -2.22 |
| 2025-04-30 | -3.00 |
| 2025-04-29 | -3.33 |
| 2025-04-28 | -3.27 |
| 2025-04-25 | -3.28 |
| 2025-04-24 | -3.26 |
| 2025-04-23 | -3.12 |
| 2025-04-22 | -2.95 |
| 2025-04-21 | -2.77 |
| 2025-04-17 | -2.77 |
| 2025-04-16 | -2.97 |
| 2025-04-15 | -3.07 |